Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Nature Medicine

• Publication date

  1996-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm0596-545PMID 8616713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

  1995cited by this paper
• Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.

  1995cited by this paper
• Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration

  1995cited by this paper
• Adenovirus and adeno-associated virus mediated gene transfer.

  1995cited by this paper
• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

  1995cited by this paper
• Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus.

  1994cited by this paper
• Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.

  1994cited by this paper
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

  1994cited by this paper
• Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis

  1994cited by this paper
• Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2a

  1994cited by this paper
• MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

  1994cited by this paper
• In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses.

  1994cited by this paper
• Adenovirus‐Mediated in Vivo Gene Transfer

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Gene therapy: adenovirus vectors.

  1993cited by this paper
• Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Biological Efficacy Study

  1993cited by this paper
• Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses

  1993cited by this paper
• Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Toxicity Study

  1993cited by this paper
• Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

  1993cited by this paper
• Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c.

  1992cited by this paper
• In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

  1992cited by this paper
• Adenovirus as an expression vector in muscle cells in vivo.

  1992cited by this paper
• Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1A is immunodominant in H-2b, but not in H-2d or H-2k mice.

  1991cited by this paper
• Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

  1991cited by this paper
• Induction of autoreactive B cells allows priming of autoreactive T cells

  1991cited by this paper
• Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

  1990cited by this paper
• Virus-induced autoantibody response to a transgenic viral antigen

  1990cited by this paper
• Cloning, sequencing, and evolutionary analysis of the mouse erythropoietin gene

  1986cited by this paper
• Radioimmunoassay of erythropoietin.

  1981cited by this paper
• RADIOIMMUNOASSAY OF ERYTHROPOIETIN

  1981cited by this paper
• TERMINATION OF ACQUIRED IMMUNOLOGICAL TOLERANCE TO PROTEIN ANTIGENS FOLLOWING IMMUNIZATION WITH ALTERED PROTEIN ANTIGENS

  1962cited by this paper

• Advances in pharmaceutical formulation technologies for thermostable vaccine platforms considering patient-centered design

  2025cites this paper
• Gene-Silencing Therapeutic Approaches Targeting PI3K/Akt/mTOR Signaling in Degenerative Intervertebral Disk Cells: An In Vitro Comparative Study Between RNA Interference and CRISPR–Cas9

  2024cites this paper
• Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression.

  2024cites this paper
• Research progress in decellularized extracellular matrix hydrogels for intervertebral disc degeneration.

  2023cites this paper
• Genetics and Molecular Biology

  2022influential citation
• Ectopic Leptin Production by Intraocular Pancreatic Islet Organoids Ameliorates the Metabolic Phenotype of ob/ob Mice

  2021cites this paper
• Toward Biological Pacing by Cellular Delivery of Hcn2/SkM1

  2021cites this paper
• Vector Strategies to Actualize B Cell–Based Gene Therapies

  2021cites this paper
• Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors

  2021cites this paper
• ISSLS prize in basic science 2021: a novel inducible system to regulate transgene expression of TIMP1

  2021cites this paper
• Advances and Prospects in Biomaterials for Intervertebral Disk Regeneration

  2021cites this paper
• Gene Therapy Approach for Intervertebral Disc Degeneration: An Update

  2020cites this paper
• Specific Inhibition of Viral MicroRNAs by Carbon Dots-Mediated Delivery of Locked Nucleic Acids for Therapy of Virus-Induced Cancer.

  2020cites this paper
• AAV6 as an effective gene delivery vector for prolonged transgene expression in intervertebral disc cells in vivo

  2020cites this paper
• Functional Tissue Engineering of Ligament and Tendon Injuries

  2019cites this paper
• A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy

  2018cites this paper
• Gene and Cell Delivery for Intervertebral Disc Degeneration

  2018cites this paper
• Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: a review

  2018cites this paper
• Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: a review

  2018cites this paper
• Dietary sodium intake and its relationship to adiposity in young black and white adults: The African‐PREDICT study

  2018cites this paper
• Gene Therapy With Regulatory T Cells: A Beneficial Alliance

  2018cites this paper
• Application to Gene Therapy and Vaccination

  2017cites this paper
• Introduction to Gene and Stem-Cell Therapy

  2017cites this paper
• Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era

  2017cites this paper
• Deletion of p22phox-dependent oxidative stress in the hypothalamus protects against obesity by modulating β3-adrenergic mechanisms.

  2017cites this paper
• Synthesis of diblock/statistical cationic glycopolymers with pendant galactose and lysine moieties: gene delivery application and intracellular behaviors.

  2016cites this paper
• Fluorescent silicon nanoparticle-based gene carriers featuring strong photostability and feeble cytotoxicity

  2016cites this paper
• Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells.

  2016cites this paper
• Dielectric passivation layer as a substratum on localized single-cell electroporation

  2016cites this paper
• A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates

  2016cites this paper
• Size-dependent gene delivery of amine-modified silica nanoparticles

  2016cites this paper
• Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 Transgene

  2015cites this paper
• WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function

  2015cites this paper
• Delivery systems for the treatment of degenerated intervertebral discs.

  2015cites this paper
• Nucleic acid programmed polymeric nanomaterials for biological communication

  2015cites this paper
• Magnetically deliverable calcium phosphate nanoparticles for localized gene expression

  2015cites this paper
• Enamel Regeneration in Making a Bioengineered Tooth.

  2015cites this paper
• Cardiac AAV9 Gene Delivery Strategies in Adult Canines: Assessment by Long-term Serial SPECT Imaging of Sodium Iodide Symporter Expression.

  2015cites this paper
• Gene Therapy for Restoring Heart Rhythm

  2014cites this paper
• Biologics for Disk Regeneration

  2014cites this paper
• Single-cell manipulation and DNA delivery technology using atomic force microscopy and nanoneedle.

  2014cites this paper
• Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection

  2014cites this paper
• Anti-apoptotischer Gentransfer in Hornhautendothelzellen

  2014cites this paper
• The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications

  2014cites this paper
• Atomic force microscopy imaging of DNA delivery nanosystems

  2014cites this paper
• Determinants of Membrane Activity from Mutational Analysis of the HIV Fusion Peptide on siRNA Uptake Activity

  2014cites this paper
• Advanced Materials for Gene Delivery

  2014cites this paper
• Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors

  2014cites this paper
• Gene therapy approaches to disease of the cornea and anterior chamber

  2014cites this paper
• Intracellular mRNA Regulation with Self-Assembled Locked Nucleic Acid Polymer Nanoparticles

  2014cites this paper
• Arginine-based biodegradable ether-ester polymers with low cytotoxicity as potential gene carriers.

  2014cites this paper
• SHOX2 Overexpression Favors Differentiation of Embryonic Stem Cells into Cardiac Pacemaker Cells, Improving Biological Pacing Ability

  2014cites this paper
• Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery.

  2013cites this paper
• biphasic liver toxicity in hemophilia A dogs results in short-term phenotypic correction, inhibitor development, and Systemic delivery of an adenoviral vector encoding canine factor VIII

  2013cites this paper
• Calcium phosphate/octadecyl-quatemized carboxymethyl chitosan nanoparticles: an efficient and promising carrier for gene transfection.

  2013cites this paper
• Murine and Nonhuman Primate Lungs Responses to Adenovirus Vectors Delivered to Role of E4 in Eliciting CD4 T-Cell and B-Cell

  2013cites this paper
• MiceHLA-Transgenic Human Immune System Hepatotropic Virus Infection in Adaptive Immune Responses during Characterization of Human Antiviral

  2013cites this paper
• Seroprevalence of neutralizing antibodies to human adenoviruses type‐5 and type‐26 and chimpanzee adenovirus type‐68 in healthy Chinese adults

  2013cites this paper
• Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice

  2013cites this paper
• EGFP-transgenic skin grafts in mice EGFP-expressing bone marrow and subsequent acceptance of Nonmyeloablative conditioning is sufficient to allow engraftment of

  2013cites this paper
• Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.

  2012cites this paper
• The Potential of Tissue Engineering and Regeneration for CraniofacialBone

  2012cites this paper
• 10 – Nanotechnology for DNA and RNA delivery

  2012cites this paper
• CC Chemokine receptor 5 deficiency does not prevent local immune responses to adenovirus vector in islet transplant recipients.

  2012cites this paper
• Development of a Topical Protein Therapeutic for Human Papillomavirus and Associated Cancers

  2012cites this paper
• Seeing the electroporative uptake of cell-membrane impermeable fluorescent molecules and nanoparticles.

  2012cites this paper
• Novel gene therapeutic approaches to prolong corneal allograft survival

  2012cites this paper
• A cell-specific poly(ethylene glycol) derivative with a wheat-like structure for efficient gene delivery.

  2012cites this paper
• A convenient method of preparing gene vector for real time monitoring transfection process based on the quantum dots

  2012cites this paper
• Strategies for efficient transfection of CHO-cells with plasmid DNA.

  2012cites this paper
• Alanina aminotransferasa en Sparus aurata: control de la expresión génica mediante RNAi y de la actividad enzimática por aminooxiacetato

  2012cites this paper
• Detection of EPO gene doping in blood.

  2012cites this paper
• Cytokine-Conditioned Dendritic Cells Induce Humoral Tolerance to Protein Therapy in Mice

  2012cites this paper
• Prostate cancer vaccines in clinical trials

  2012cites this paper
• Use of DAF-Displaying Adenovirus Vectors Reduces Induction of Transgene- and Vector-Specific Adaptive Immune Responses in Mice

  2011cites this paper
• Atomic Force Microscopy Studies of DNA Release in Gene Delivery Dynamics

  2011cites this paper
• Gene therapy for intervertebral disk degeneration.

  2011cites this paper
• Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.

  2011cites this paper
• Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.

  2011cites this paper
• Skin Gene and Cell Therapy

  2011cites this paper
• Immune Modulation for Stem Cell Therapy

  2011cites this paper
• Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm

  2011cites this paper
• Development of adenoviral vector-based mucosal vaccine against influenza

  2011cites this paper
• Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain.

  2011cites this paper
• Gene therapy: light is finally in the tunnel

  2011cites this paper
• New tumor-targeted nanosized delivery carrier for oligonucleotides: characteristics in vitro and in vivo

  2011cites this paper
• Developing live vaccines against Yersinia pestis

  2011cites this paper
• Construction and evaluation of high-capacity adenoviral vectors for gene therapy applications

  2011cites this paper
• RNA interference therapy via functionalized scaffolds.

  2011cites this paper
• Rational Design of Murine Secreted Alkaline Phosphatase for Enhanced Performance as a Reporter Gene in Mouse Gene Therapy Preclinical Studies

  2011cites this paper
• Adenovirus Gene Transfer to Amelogenesis Imperfecta Ameloblast-Like Cells

  2011cites this paper
• Virale Vektoren für den Gentransfer in korneale Endothelzellen

  2011cites this paper
• Generation and functionality of a novel, Cox2-controlled, conditionally-replicating, adenovirus expressing interferon alpha for pancreatic cancer therapy.

  2011cites this paper
• Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting

  2011cites this paper
• Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.

  2011cites this paper
• Shutdown of immunological priming and presentation after in vivo administration of adenovirus

  2011cites this paper
• Anti-tumor effect of adenoviral vector-mediated p53 gene transfer on the growth of canine osteosarcoma xenografts in nude mice.

  2011cites this paper
• Developing live vaccines against plague.

  2011cites this paper
• Systemic gene delivery for muscle gene therapy

  2010cites this paper
• Adenovirus vaccine immunotherapy targeting WT1-expressing tumors

  2010cites this paper